69 compounds | Property perm: Corneal permeability [cm/s]
| ID | Name | perm | Ref | Details |
|---|---|---|---|---|
| 1 | Acetazolamide | 9.1E-7 | [1,2] | View |
| 2 | Alprenolol | 2.9E-5 | [3] | View |
| 3 | Atenolol | 6.7E-7 | [4] | View |
| 4 | Benzolamide | 1.4E-7 | [1] | View |
| 5 | Bevantolol | 5.4E-5 | [4] | View |
| 6 | N-bromoacetazolamide | 3.8E-7 | [1] | View |
| 7 | Bufuralol | 5.7E-5 | [4] | View |
| 8 | Chlorzolamide | 1.8E-5 | [1] | View |
| 9 | Clonidine | 3.1E-5 | [3,5] | View |
| 10 | Corynanthine | 1.1E-5 | [5] | View |
| 11 | Cyclophosphamide | 1.1E-5 | [6] | View |
| 12 | Ethoxazolamide | 5.6E-5 | [1] | View |
| 13 | 2-benzothiazolesulfonamide | 3.6E-5 | [7] | View |
| 14 | 6-hydroxy-2-benzo-thiazolesulfonamide | 5.6E-6 | [7] | View |
| 15 | 6-chloro-2-benzo-thiazolesulfonamide | 4.3E-5 | [7] | View |
| 16 | 4,6-dichloro-2-benzo-thiazolesulfonamide | 3.9E-5 | [7] | View |
| 17 | 6-amino-2-benzo-thiazolesulfonamide | 6.7E-6 | [7] | View |
| 18 | 6-nitro-2-benzo-thiazolesulfonamide | 6.6E-6 | [7] | View |
| 19 | 6-hydroxyethoxy-2-benzothiazolesulfonamide | 1.5E-6 | [7] | View |
| 20 | 6-benzyloxy-2-benzo-thiazolesulfonamide | 4.7E-5 | [7] | View |
| 21 | 6-acetamido-2-benzo-thiazolesulfonamide | 4.7E-6 | [7] | View |
| 22 | Levobunolol | 2.0E-5 | [3,4] | View |
| 23 | Labetalol | 1.4E-5 | [3] | View |
| 24 | Methazolamide | 2.6E-6 | [1] | View |
| 25 | 5-imino-4-methyl-1,3,4-thiadiazoline-2-sulfonamide | 7.8E-7 | [1] | View |
| 26 | Metoprolol | 2.5E-5 | [3,4] | View |
| 27 | Nadolol | 1.0E-6 | [4] | View |
| 28 | Oxprenolol | 2.9E-5 | [3,4] | View |
| 29 | Penbutolol | 4.5E-5 | [4] | View |
| 30 | Phenylephrine | 9.4E-7 | [5] | View |
| 31 | Pindolol | 1.0E-5 | [3] | View |
| 32 | Propranolol | 4.8E-5 | [4] | View |
| 33 | Rauwolfine | 9.2E-6 | [5] | View |
| 34 | 6H,7H,8H,9H-[1,2,3]thiadiazolo[5,4-h]isoquinoline i | 7.9E-5 | [5] | View |
| 35 | Benalfocin i | 7.1E-5 | [5] | View |
| 36 | 5,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline i | 4.9E-5 | [5] | View |
| 37 | Sotalol | 1.6E-6 | [4] | View |
| 38 | 1[(N-methylamino) sulfonyl]-4-chloro-benzene | 6.5E-5 | [2] | View |
| 39 | 4-chlorobenzene-1-sulfonamide | 5.5E-5 | [2] | View |
| 40 | (3Z)-3-(phenylimino)-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 7.9E-6 | [8] | View |
| 41 | (3Z)-3-[(3-chlorophenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 1.3E-5 | [8] | View |
| 42 | (3Z)-3-[(4-chlorophenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 8.3E-6 | [8] | View |
| 43 | (3Z)-3-[(3-methoxyphenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 4.5E-6 | [8] | View |
| 44 | (3Z)-3-[(4-methoxyphenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 5.2E-6 | [8] | View |
| 45 | (3Z)-3-[(4-hydroxyphenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 3.5E-7 | [8] | View |
| 46 | (3Z)-3-[(3-fluorophenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 6.4E-6 | [8] | View |
| 47 | (3Z)-3-[(4-fluorophenyl)imino]-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 4.1E-6 | [8] | View |
| 48 | (3Z)-3-{[4-(dimethylamino)phenyl]imino}-[1,2,4]thiadiazolo[3,4-b][1,3,4]thiadiazole-6-sulfonamide i | 5.8E-6 | [8] | View |
| 49 | Timolol | 1.2E-5 | [3,4] | View |
| 50 | Trichlormethazolamide | 1.1E-5 | [1,9] | View |
| 51 | Trifluormethazolamide | 3.9E-6 | [1] | View |
| 52 | Yohimbine | 1.8E-5 | [5] | View |
| 53 | Cinoxacin | 1.5E-6 | [10] | View |
| 54 | Nalidixic acid | 1.7E-5 | [10] | View |
| 55 | Enoxacin | 1.7E-6 | [10] | View |
| 56 | Norfloxacin | 1.4E-6 | [10] | View |
| 57 | Ofloxacin | 1.9E-6 | [10] | View |
| 58 | Ciprofloxacin | 1.3E-6 | [10] | View |
| 59 | Moxifloxacin | 9.1E-6 | [11] | View |
| 60 | Levofloxacin | 2.9E-6 | [11] | View |
| 61 | Gatifloxacin | 2.5E-6 | [11] | View |
| 62 | Lomefloxacin | 3.5E-6 | [11] | View |
| 63 | Buspirone | 6.65E-5 | [11] | View |
| 64 | Apraclonidine | 3.8E-6 | [11] | View |
| 65 | Fluorescein | 1.6E-5 | [11] | View |
| 66 | Pilocarpine | 9.8E-6 | [11] | View |
| 67 | Nepafenac | 7.4E-5 | [11] | View |
| 68 | Betaxolol | 6.0E-5 | [11] | View |
| 69 | Dexamethasone | 9.2E-6 | [11] | View |
Duffel, M. W.; Ing, I. S.; Segarra, T. M.; Dixson, J. A.; Barfknecht, C. F.; Schoenwald, R. D. N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure. Journal of Medicinal Chemistry 1986, 29, 1488–1494. https://doi.org/10.1021/jm00158a028
Maren, T. H.; Jankowska, L.; Sanyal, G.; Edelhauser, H. F. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Experimental Eye Research 1983, 36, 457–479. https://doi.org/10.1016/0014-4835(83)90041-6
Wang, W.; Sasaki, H.; Chien, D.-S.; Lee, V. H. L. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: A comparison with corneal penetration. Current Eye Research 1991, 10, 571–579. https://doi.org/10.3109/02713689109001766
Lach, J. L.; Huang, H.-S.; Schoenwald, R. D. Corneal Penetration Behavior of β-Blocking Agents II: Assessment of Barrier Contributions. Journal of Pharmaceutical Sciences 1983, 72, 1272–1279. https://doi.org/10.1002/jps.2600721109
Chiang, C.-H.; Schoenwald, R. D. Ocular pharmacokinetic models of clonidine-3H hydrochloride. Journal of Pharmacokinetics and Biopharmaceutics 1986, 14, 175–211. https://doi.org/10.1007/bf01065260
Chiang, C.; Schoenwald, R.; Huang, H. Corneal permeability of adrenergic agents potentially useful in glaucoma. J Taiwan Pharmaceut Assoc 1986, 38, 67–84.
Schoenwald, R. D.; Houseman, J. A. Disposition of cyclophosphamide in the rabbit and human cornea. Biopharmaceutics & Drug Disposition 1982, 3, 231–241. https://doi.org/10.1002/bdd.2510030306
Eller, M. G.; Schoenwald, R. D.; Dixson, J. A.; Segarra, T.; Barfknecht, C. F. Topical Carbonic Anhydrase Inhibitors III: Optimization Model for Corneal Penetration of Ethoxzolamide Analogues. Journal of Pharmaceutical Sciences 1985, 74, 155–160. https://doi.org/10.1002/jps.2600740210
WU, N.-C.; CHIANG, C.-H.; LEE, A.-R. Studies of Carbonic Anhydrase Inhibitors: Physicochemical Properties and Bioactivities of New Thiadiazole Derivatives. Journal of Ocular Pharmacology and Therapeutics 1993, 9, 97–108. https://doi.org/10.1089/jop.1993.9.97
Jankowska, L. M.; Bar-Ilan, A.; Maren, T. The relations between ionic and non-ionic diffusion of sulfonamides across the rabbit cornea. Investigative ophthalmology & visual science 1986, 27, 29-37.
Rusinko, A.; Hellberg, M. R.; May, J. A.; Owen, G. R. Use of mdck cell line to predict corneal penetration of drugs. 2008.